GACM
PBYI icon

Green Arrow Capital Management’s Puma Biotechnology PBYI Stock Holding History

Green Arrow Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$660K – 200
2014
Q2 		$660K Buy
+10,000
New +$711K 0.08% 147
2014
Q1 		– Sell
-10,000
Closed -$1.03M – 278
2013
Q4 		$1.03M Buy
+10,000
New +$587K 0.07% 217

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Green Arrow Capital Management's PBYI Position: Q3 2014 in Review

Green Arrow Capital Management sold out of Puma Biotechnology (PBYI) in Q3 2014, closing a stake of 10,000 shares — an estimated $660K sold.

Green Arrow Capital Management first reported a position in PBYI in Q4 2013 and held it in 2 quarters. The position peaked at $1.03M in Q4 2013. 184 funds tracked by Wall St. Rank hold PBYI as of Q3 2014.

  • Green Arrow Capital Management reported no remaining Puma Biotechnology position as of Q3 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 10,000 Puma Biotechnology shares in Q3 2014, an estimated $660K.
  • Green Arrow Capital Management first reported a position in Puma Biotechnology in Q4 2013 and held it in 2 quarters.
  • Green Arrow Capital Management's Puma Biotechnology position peaked at $1.03M in Q4 2013.
  • 184 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2014.

Based on Green Arrow Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.